TP53 and cancer: In line with this finding, we observed early acquisition of TP53 mutations in all 3 patients, a high number of copy-number gains and losses in many cancer-related and other genes in these samples, followed by transient instability, with discordant copy-number profiles in 40%, 22.54%, and 40.21% reduced segments, respectively, in sequential samples from the 3 patients.